ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Review
Revised

A review of ultrasound contrast media

[version 3; peer review: 2 approved]
PUBLISHED 04 Jun 2024
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Efforts have been made over the last five decades to create effective ultrasonic contrast media (UCM) for cardiac and noncardiac applications. The initial UCM was established in the 1980s, following publications from the 1960s that detailed the discovery of ultrasonic contrast enhancement using small gaseous bubbles in echocardiographic examinations. An optimal contrast agent for echography should possess the following characteristics: non-toxicity, suitability for intravenous injection, ability to traverse pulmonary, cardiac, and capillary circulations, and stability for recirculation. Definity, Optison, Sonazoid, and SonoVue are examples of current commercial contrast media. These contrast media have shown potential for various clinical reasons, both on-label and off-label. Several possible UCMs have been developed or are in progress. Advancements in comprehending the physical, chemical, and biological characteristics of microbubbles have significantly improved the visualization of tumor blood vessels, the identification of areas with reduced blood supply, and the enhanced detection of narrowed blood vessels. Innovative advances are expected to enhance future applications such as ultrasonic molecular imaging and therapeutic utilization of microbubbles.

Keywords

contrast agents for ultrasound, Microbubbles, echocardiographic, M-mode

Revised Amendments from Version 2

1. The grammatical and typo errors in all manuscript sections are corrected.
2. The conclusion is rephrased in a good Scientific way.

See the author's detailed response to the review by Hamad Yahia Abu Mhanna
See the author's detailed response to the review by Haytham Alewaidat

Introduction

In obstetrics, cardiology, and radiology, ultrasound imaging is a common clinical tool for the morphological examination of soft tissues.17 As an ultrasonic wave—a longitudinal wave—travels through the body, tissue surfaces with various acoustic characteristics, such as speed of sound and density, produce reflections. The same transmitting transducer captures these scattered impulses and uses them to create an image. However, because to the size and characteristics of red blood cells, the intrinsic scattering from the blood pool is often several orders of magnitude lower than tissue at standard diagnostic frequencies (1–9 MHz). As a result, blood appears black on typical ultrasound images, making it difficult to determine the properties of blood flow. Doppler techniques can be used to measure blood velocity in bigger veins by comparing the relative motion of red blood cells to the surrounding tissue.8,9 This technique is frequently used in clinical settings (e.g., obstetrics,10 assessment of peripheral artery disease,11 cardiology12). However, this method has drawbacks when applied to areas with poor blood flow, significant tissue motion, and/or low hematocrit percentage.1315

Ultrasound imaging’s diagnostic applications have significantly expanded during the past few decades. The advancement of UCM has resulted in the presentation of valuable physiological and pathological information, as well as the accessibility of perfusion imaging for cardiac or tumor tissue in routine clinical decision-making.16,17 The early 1960s saw the first reports of the ultrasonic contrast effect was studies by Joyner. Further research revealed the existence of UCM made of saline, indocyanine green, hydrogen peroxide, dextrose, and renografin.16,18 UCM comprise of a suspension of small spheres of gas with a poor solubility in blood (e.g., perfluorocarbon), often ranging in size from below 10 μm in diameter. The relatively large size of UCMs guarantees that they remain strictly intravascular and function as red blood cell tracers, in contrast to contrast media employed in other modalities like (magnetic resonance imaging) MRI and computer tomography (CT).19

Around 1980, achieving stability long enough for the UCM to reach the correct heart was one of the primary objectives in creating efficient UCMs. Left heart contrast was not possible until the 1990s because lung capillaries are effective filters. In 1995, contrast-enhancing substances with enhanced blood pool enhancement capabilities first surfaced. The next goal was to create bubbles that would allow for real-time imaging. In order to achieve this, air was substituted with weakly soluble gases, such as perfluorocarbons, which increased bubble endurance and allowed the development of software algorithms that could effectively distinguish UCM from tissue signals.2023

Microbubbles vibrate about their equilibrium radius in an ultrasonic field due to the compressibility of their gas cores, and they have scattering cross-sections that are many orders of magnitude higher than a solid particle of the same size.16,24,25 A thin biocompatible encapsulation layer, often a phospholipid monolayer, stabilizes the bubbles by striking a balance between their ability to vibrate freely and their resistance to dissolving in-vivo during timeframes important for imaging, like half-lives of minutes.26,27

Contrast echocardiography has a virtually limitless potential. Contrast echocardiography is currently the subject of extensive interest and research, as this review demonstrates. The creation of novel contrast-producing chemicals is arguably the most intriguing component of this research. It will be fascinating to watch how these different agents grow. Ideally, one or more of these novel agents will be able to cross the capillaries, allowing for peripheral venous injection-based visualization of the left side of the heart.

Emerging technique

Over the world, contrast-enhanced ultrasound imaging is used in numerous medical and off-label applications. On multiple fronts, including the creation of novel pulse sequences and image processing techniques, the development of devices, and the creation of remote monitoring for ultrasonic therapies, this field is seeing cutting-edge breakthroughs at the same time.

Contrast media

The only UCM that has received clinical approval is microbubbles. These bubbles have the advantage of remaining intravascular because of their size, making it possible to perform diagnostic tests that would be challenging with diffusible tracers. The use of these “conventional” UCM is being expanded, though, to include molecular-based imaging, imaging of the extravascular space, and as a platform for both imaging and therapeutic administration.2832

Creation of the “optimal” UCM

Extensive study was done beginning in 1980 to establish contrast echocardiography as a recognized diagnostic method.33 Ophir and Parker (1989) provided a summary of UCM’s application in medical imaging.34 Free gas bubbles, encapsulated gas bubbles, colloidal suspensions, emulsions, and aqueous solutions were the five categories of agents that were categorized according to their physical characteristics. Producing the “perfect” contrast media that would satisfy the following requirements was still a major difficulty in those days. Such as, distribution of the substance inside the myocardial or heart chambers, which is indicative of regional blood flow; agent’s capacity to endure after an intravenous infusion during an imaging test; containing microbubbles with a diameter of less than 8 mm (smaller than red blood cells), allowing passage via the pulmonary system and the body’s smallest capillaries; good safety profile, physiological inert; and strong, regulated, and echogenic acoustic interaction.

Synthesis of functionalized microbubbles

In 1984 (Feinstein et al. 1984), cavitation was used to create microbubbles after inserting the tip of a sonicator horn into a solution of human serum albumin.17 This solved the problem of creating stable encapsulated microbubbles that could survive passage through the heart and the pulmonary capillary network. After a peripheral venous injection, these microbubbles could be seen in the left heart. Due to the creation of functionalized microbubbles,35 or microbubbles with one or more targeted moieties inserted into the phospholipid encapsulation,36 non-invasive imaging of pathophysiological events has recently been demonstrated to be viable with ultrasound. Target sites have focused on internal vasculature processes such inflammation,37 angiogenesis,38 and thrombus formation39 since microbubbles are purely intravascular. See Table 1.

Table 1. Lists the most popular microbubble-based intravenous UCM at various stages of development.40

Trademark nameManufacturerFormulations
BispherePoint BiomedicalAlbumin/air
EchogenSonus PharmaceuticalsSurfactant
EchovistSchering AGGalactose/air
OptisonAmersham Health Inc.Protein-type A/perfluoropropane

The development of the first microbubbles that met the majority of the requirements for an intravenous UCM also sparked intense research by doctors, scientists, and the makers of ultrasound equipment to explain the physical phenomena and apply what they learned to therapeutic settings.

There were several technologies looked at to stabilize the microbubbles. For the purpose of lowering surface tension and stabilizing the gas core against quick dissolution, thin shells consisting of protein, polymer, or phospholipids were utilized. Unfortunately, due to the high solubility of air in water, the first-generation agents still had poor stability and relatively short circulation times. By substituting perfluorinated gases with low solubility in water, such as sulphur hexafluoride, perfluoropropane, or perfluorobutane for air during circulation, persistence during circulation was dramatically improved, resulting in sufficient persistence of the agent in the blood circulation for clinical use.41

There are many ultrasound-sensitive sub-micron agents currently being researched. This research is motivated by the enhanced-permeability and retention effect,42 whereby small nanometer sized particles locally extravasate from leaky blood vessels and accumulate in the perivascular space of solid tumors. Phase-shift droplets,43 nanobubbles,44 gas vesicles,45 echogenic liposomes,46 and polymeric nanoparticles47 are a few of the more common examples. Although research into the physics of acoustic droplet vaporization is still ongoing, it is most probable that both intrinsic and external elements play a role in the process.

Ultrasound imaging techniques using UCM

Vibrating microbubbles’ nonlinear nature is essential to their efficiency as an ultrasonic contrast agent. These emissions allow for the separation of bubble signals from the surrounding (about linear) tissue from those within tiny vessels. Thus, certain microbubble imaging modes were created concurrently with the advancements in UCM and as a result of a better knowledge of non-linear microbubble behavior; these are now used in the majority of clinical ultrasound systems.4850 The first methods of bubble identification were harmonic imaging, which involved gathering and filtering energy from the receive signal at the second harmonic, which is twice the driving frequency. Because the second harmonic signal produced by microbubbles is substantially greater than the second harmonic signal produced by tissue, it has a higher signal-to-noise ratio than the fundamental energy. The success of low mechanical index (MI) (0.1) contrast-specific imaging, which is primarily employed for real-time perfusion and intra-cavitary measurements, is particularly explained by the non-linear shell behavior. Furthermore, a number of diagnostic imaging procedures and/or quantification strategies are founded on the distinct and extremely sensitive attribute of microbubble destruction.51 See Figure 1.

e6af032f-0c89-4e70-9adb-055272c5fa6c_figure1.gif

Figure 1. Microbubble-specific imaging sequences capture the nonlinear signal from the contrast agent while excluding tissue with linear scattering.

Pulse inversion diagram (A). Two 180-degree pulses produce tissue echoes that are out of phase. Microbubbles are nonlinear; hence, this is not true. Microbubbles produce a strong echo, while linear tissue almost totally cancels it off. B-mode and contrast-specific imaging of an 8-mm artery phantom exhibit microbubble-specific imaging's improved vascular contrast. The Philips iU22 scanner, C5-2 probe, and DefinityTM contrast medium were used to record this. This source provides this number. Microbubble-specific imaging sequences exclude linear scattering tissue and capture a nonlinear contrast agent signal. Yusefi, H., & Helfield, B. (2022), https://www.frontiersin.org/files/Articles/791145/fphy-10-791145-HTML/image_m/fphy-10-791145-g002.jpg, CC BY 4.0.28

In other words, the reflection pattern from the bubble to the ultrasound signal is significantly altered by UCM. They start by greatly boosting the backscattered signal.23 UCM resonate linearly in response to acoustic pressure. Acoustic pressure increases cause nonlinear vibrational patterns to manifest.52 Only at higher mechanical indices (MI) do tissues create harmonic resonances, making it easy to distinguish between the signal’s tissue or UCM origin. Multiples of the natural frequencies are received using filter devices, allowing for some background (non-UCM) signal reduction. Microbubbles are disrupted by high pressure levels, which results in strong signals and signals with various properties.

M-mode echocardiograms using UCM

Understanding the interaction between ultrasonic waves and gaseous microbubbles was made much easier by using the process utilized to explain the set of echoes first discovered on M-mode echocardiograms. The strong compressibility of the gas core appears to be particularly significant since it produces frequency-dependent volume pulsations with a clear maximum at the resonance frequency, which is inversely proportional to the size of the microbubbles.24,53 However, In the following circumstances, UCM is advised by cardiologic guidelines: if the left ventricular (LV) cavum does not have two continuous segments, If the original spectrum signals are insufficient, to enhance Doppler evaluations, when periodic evaluation of the ejection fraction is necessary given the reduced variability caused by UCM, and in the case of Takotsubo myopathy, left ventricular (LV) aneurysms, and intracavitary thrombi.52,54,55

Microbubbles-based color Doppler ultrasound

Acoustic color Doppler is an imaging method that overlays color-coded maps of tissue velocity on grey-scale images of tissue anatomy. It combines anatomical information acquired from ultrasonic pulse-echo techniques with velocity information derived from ultrasonic Doppler techniques. The technique is most frequently used to visualize blood flow through the heart, arteries, and veins, but it can also be used to visualize the movements of solid tissues like the walls of the heart. vectors. Almost all commercial ultrasound equipment now provides color Doppler imaging, which has been proven to be very useful in determining blood flow in a variety of clinical circumstances. Although the technique for getting velocity information is quite similar to the technique for getting anatomical information, there are a number of reasons why it is technically more difficult. It also has a few flaws, the biggest of which is that, in conventional systems, the velocities measured and subsequently displayed are the components of the flow velocity directly towards or away from the transducer, whereas the method’s ideal output would provide data on the magnitude and direction of the three-dimensional flow vectors.5661

In conjunction with color or power Doppler, stimulated acoustic emission is employed in high mechanical index (MI) imaging. A high MI ultrasound impulse is used to deflate the microbubbles, and the signal that is received is a complicated mixture of ultrasound waves that causes a Doppler shift.62 It is especially helpful when a UCM with tissue specificity, is in its late stages.20 Color Doppler imaging has been shown that despite the poor spatial resolution, real-time imaging was possible due to the tiny size of the picture window.63

Recently, the use of ultrasound color Doppler has been shown to monitor bubbles during ultrasound therapy. An active ultrasound imaging method called color Doppler uses the phase shifts between the echoes of imaging pulses to measure velocities. In the aforementioned investigation, an increase in the color Doppler signal was connected with the formation of cavitation bubbles on their own under a high-pressure ultrasonic beam. The rise was utilized to evaluate tissue fractionation and was related to the mobility of the surrounding tissue brought on by cavitation within the focused location. Although this method is helpful for high-pressure therapy, it does not reveal how net bubbles flow through the field.64,65

Modern commercial UCM

All currently marketed UCM are made up of an inert gas enclosed in a shell. The gas determines solubility and most of the acoustic qualities of the bubbles, while the shell mostly affects the viscoelastic properties, such as stability and durability.66 Perfluorocarbon bubbles, which range in size almost 10 m and are real blood pool agents, allow transit through the pulmonary vascular system, which is necessary for entry to the systemic circulation.52 Soft shell materials have better nonlinear oscillations and are made of phospholipids or other surfactants.67 There are also protein-shelled microbubbles that contain an albumin shell around perfluoropropane gas.

Conclusion

Contrast agent microbubble vibration basics and its applications in common contrast-imaging are outlined in this paper. Over the span of the last fifty years, UCM imaging has made substantial progress. Previously, the primary clinical emphasis was on echocardiography, while myocardial perfusion was considered the ultimate goal and an attractive market for contrast echo. The primary purpose of echocardiography was to enhance the visibility of the LV by making it more opaque, hence improving the clarity of the LV endocardial border. UCM imaging is a safe and effective method for many clinical applications, and its use is growing. Due to increased clinical awareness of ultrasound’s advantages as well as collaborative research projects between physicists, chemists, engineers, and clinicians on the study of microbubble behavior, signal processing methods, contrast agent synthesis, and device development, this imaging technology has achieved tremendous success to date.

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 07 Nov 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Oglat AA. A review of ultrasound contrast media [version 3; peer review: 2 approved]. F1000Research 2024, 12:1444 (https://doi.org/10.12688/f1000research.140131.3)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 11 Mar 2024
Revised
Views
8
Cite
Reviewer Report 29 May 2024
Haytham Alewaidat, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan 
Approved
VIEWS 8
This review shows An ideal contrast medium for echography should be nontoxic, capable of being injected intravenously, able to travel through pulmonary, cardiac, and capillary circulations, and stable for recirculation
The comments are below:
The author mentioned each detail ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Alewaidat H. Reviewer Report For: A review of ultrasound contrast media [version 3; peer review: 2 approved]. F1000Research 2024, 12:1444 (https://doi.org/10.5256/f1000research.163423.r254669)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Jun 2024
    Ammar A. Oglat, Department of Medical Imaging, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, 13133, Jordan., The Hashemite University, Az-Zarqa, 13133, Jordan
    10 Jun 2024
    Author Response
    Responses to Reviewer’s Comments

    Title:  A review of ultrasound contrast media

    Dear Editor-in-Chief,

    The author sincerely appreciates the reviewers’ technical comments and the useful suggestions offered to ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Jun 2024
    Ammar A. Oglat, Department of Medical Imaging, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, 13133, Jordan., The Hashemite University, Az-Zarqa, 13133, Jordan
    10 Jun 2024
    Author Response
    Responses to Reviewer’s Comments

    Title:  A review of ultrasound contrast media

    Dear Editor-in-Chief,

    The author sincerely appreciates the reviewers’ technical comments and the useful suggestions offered to ... Continue reading
Views
11
Cite
Reviewer Report 27 Mar 2024
Hamad Yahia Abu Mhanna, Universiti Sains Malaysia, Minden Heights, Pulau Pinang, Malaysia 
Approved
VIEWS 11
I agree with ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Abu Mhanna HY. Reviewer Report For: A review of ultrasound contrast media [version 3; peer review: 2 approved]. F1000Research 2024, 12:1444 (https://doi.org/10.5256/f1000research.163423.r254568)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 07 Nov 2023
Views
16
Cite
Reviewer Report 05 Mar 2024
Hamad Yahia Abu Mhanna, Universiti Sains Malaysia, Minden Heights, Pulau Pinang, Malaysia 
Approved
VIEWS 16
 Minor comments:
 
  1. The title is accurately representing the content of the article.
  2. Kindly make the contribution of this review clearer in the abstract section.
  3. In the abstract section, please rephrase
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Abu Mhanna HY. Reviewer Report For: A review of ultrasound contrast media [version 3; peer review: 2 approved]. F1000Research 2024, 12:1444 (https://doi.org/10.5256/f1000research.153460.r248551)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 04 Apr 2024
    Ammar A. Oglat, Department of Medical Imaging, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, 13133, Jordan., The Hashemite University, Az-Zarqa, 13133, Jordan
    04 Apr 2024
    Author Response
    Responses to Reviewer’s Comments

    Title:  A review of ultrasound contrast media

    Dear Editor-in-Chief,

    The author sincerely appreciates the reviewers’ technical comments and the useful suggestions offered to ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 04 Apr 2024
    Ammar A. Oglat, Department of Medical Imaging, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, 13133, Jordan., The Hashemite University, Az-Zarqa, 13133, Jordan
    04 Apr 2024
    Author Response
    Responses to Reviewer’s Comments

    Title:  A review of ultrasound contrast media

    Dear Editor-in-Chief,

    The author sincerely appreciates the reviewers’ technical comments and the useful suggestions offered to ... Continue reading

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 07 Nov 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.